Answer
Xeplion (paliperidone palmitate) is contraindicated in people with hypersensitivity to paliperidone palmitate, risperidone or any excipient listed in section 6.1.
Sources for this answer
- XEPLION 150 mg prolonged release suspension for injectionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 4Document updated
Sources checked